Background: Deep brain stimulation (DBS) of the basal ganglia is an evolving technique for managing intractable movement disorders such as those due to Parkinson disease. We conducted a retrospective review of the DBS procedures that have been performed at our institution to determine the frequency and types complications that occurred.
D eep brain stimulation (DBS) is a procedure which presents many anesthetic challenges. The goal of this therapy is to enhance the quality of life for patients with Parkinson disease and other chronic neurologic disorders. 1 Various subcortical structures within the basal ganglia, including the subthalamic nucleus, the globus pallidus and the thalamus, are the targets of stimulation. 2 The challenges facing anesthesiologists during intracranial electrode placement result from a combination of factors. These procedures tend to be long in duration, the patients are unable to alter their position once the procedure is underway, and anesthesiologists are not able to provide patients with many of the usual anxiolytic medications owing to the need for patient participation during physiologic localization. Moreover, anesthetic agents can interfere with the activity of neurons from which recordings are made, therefore affecting the physiologic mapping process. Long-term complications of this procedure, including hardware-related failures, infections, and intracerebral hemorrhage have been well recognized; however, complications occurring during the perioperative period need to be further studied. [3] [4] [5] [6] [7] [8] [9] We conducted a retrospective review of the DBS procedures performed in our institution to determine the frequency and type of perioperative complications. In addition, we attempted to determine whether patient-specific characteristics might be predictive of complications.
METHODOLOGY
After receiving Institutional Review Board approval, 258 DBS procedures involving 250 patients at Cleveland Clinic were retrospectively reviewed for intraoperative complications. We reviewed discharge summaries, anesthetic records, and operative reports for procedures performed between 1999 and 2003. Patient characteristics recorded included age, body mass index, ASA physical status, number of DBS procedures, target location, smoker/nonsmoker status, presence of Parkinson disease, and comorbid conditions. Because of the retrospective nature of this study, the authors did not influence the anesthetic management for these procedures. All procedures were done in the supine position. In most of the patients the anesthetic plan involved monitored anesthesia care with local anesthetic infiltration of the scalp; general anesthesia with endotracheal intubation was used only in non-cooperative patients.
Cardiac complications were defined as intraoperative or postoperative myocardial infarction, new onset angina, new onset of congestive heart failure, and refractory systemic arterial hypertension. Respiratory complications were defined as respiratory arrest or severe airway obstruction that required endotracheal intubation, prolonged endotracheal intubation, postoperative acute respiratory distress syndrome, nosocomial pneumonia, and aspiration. Neurologic complications included new onset stroke or transitory ischemic attack, intraoperative or postoperative intracranial bleeding, and seizures. Psychologic/psychiatric complications were defined as confusion syndrome, anxiety, delirium, and withdrawal syndromes.
Statistical Method
Patients with and without complications were compared regarding potential risk factors using the Chi-square test (Fisher exact test if expected cell counts less than 5) for the categorical variables and t-test for the continuous variables.
RESULTS
Two hundred and fifty patients were studied. One hundred sixty-four were male and eighty-six were female. The average age was 59.4 ± 13.4 years-old. One hundred seventy-eight procedures (68%) were performed in patients with Parkinson disease and the rest (32%) were done in patients with other motor disorders. Bilateral placement of DBS was performed in one hundred and seventy two of the patients (68.8%). The most common co-morbidities were cigarette smoking (88%) and obesity (86%). Other less frequent co-morbidities were systemic hypertension (21%), gastroesophageal reflux disease (10%) and coronary artery disease (6.4%).
In all procedures standard anesthetic monitoring (ASA criteria) were applied. The most common anesthesia technique consisted of the intravenous infusion of propofol as a sole agent and was used in 237 procedures (91%). The mean infusion dose of propofol was 67.2 ± 53.2 mg/kg/min. In the vast majority of cases, propofol was used only during the first 30 to 45 minutes of the case to facilitate head-frame placement. Other much less frequent anesthetic techniques used were combinations of propofol plus opioids (2.3%), inhalatory agents plus opioids and muscle relaxants (1.5%), dexmedetodine with ketamine (0.3%), dexmedetomidine alone (0.3%), remifentanil plus midazolam (0.3%) and opioids alone (0.3%). Only seven procedures (2.3%) were performed without any sedatives or anesthetic drugs. General anesthesia with endotracheal intubation was used in 7.3% of the procedures for generator insertion after placing the DBS electrodes if the permanent generator was decided to be inserted in the same day after the DBS procedure. All patients received local anesthesia before scalp incision. A head-frame was used in almost all (99.2%) but two (0.8%) procedures. The two procedures where the frame was not used were for patients with morbid obesity and with obstructive sleep apnea.
A total of twenty-nine intraoperative complications were found in our series, resulting in a total complication rate of 11.6%. These are summarized in Table 1 .
The most common neurologic complications (3.6%) were intracranial hemorrhage and seizure. Among the psychologic/psychiatric complications (3.2%), confusion and anxiety were the most frequent. The rate of major complications was 5.6%. Two patients requested termination of their procedure, and both had evidence of a small intracranial hemorrhage. One was completely conscious; while another requested termination of the procedure because of leg cramping. None of the complications resulted in mortality. Tables 2 and 3 compare patients with and without complications on the potential risk factors. Since age was the only significant difference between the groups, no multivariable model was performed. The only independent risk factor observed for complications during the procedure was age.
DISCUSSION
Deep brain stimulation is an alternative treatment for patients with Parkinson disease (PD), essential and cerebellar outflow tremors, and dystonia. Anesthesia for DBS placement represents a challenge because of the complex neurocircuitry in the central nervous system and because of the comorbities suffered by patients with movement disorders. Also, the perioperative circumstances impose an extensive knowledge requirement concerning the technical details associated with this procedure. Age has been implicated previously as an important factor in the occurrence of perioperative complications, and elderly patients above the age of 70 years are usually excluded. 10 Our results establish that age Z64 is the single most important independent factor for complications during DBS. We speculate that the association between age and complications noted in the study could be explained that with increased age the ability of the body to withstand other comorbidities become less and could succumb easily to their effects under lengthy and stressful procedures like DBS. Patient selection and preparation for the procedure are very For instance, aspirin and coumadin should be stopped. Blood pressure must be well controlled to avoid development of hematomas (subdural, subarachnoid, intraventricular or intracerebral). Overall, the rate of hemorrhage has been estimated approximately 3% to 5% per patient for bilateral procedures. 9 Our results showed 2.8%, which is close to earlier published results.
The cessation of the anti-Parkinsonian medications before the surgery (called ''off-period'') can be very unpleasant, particularly for those patients with severe ''off-period'' pain, dystonia or depression. Moreover, during the DBS electrode placement the patient's head is usually fixed to the stereotactic apparatus, which makes these patients even more uncomfortable. Thus, sedative agents such as propofol while a burr hole is made under local anesthesia may be beneficial. Due to the complex neuronal circuitry between the striatum and the globus pallidus/SNr, and the GPE and subthalamic nucleus where GABA-ergic pathways are involved, sparing use or avoidance of anesthetic medications with GABA-ergic activity like benzodiazepines or propofol during the DBS procedure is advisable. We have also noted that some patients receiving propofol had sneezing, which has already been documented by its manufacturer. While sneezing may seem innocuous and resolves after 12 Controversy about dopaminergic therapy tapers prior to the procedure still exists; currently, there is no clear data to support gradual compared to abrupt cessation of dopaminergic medications to reduce the risk of confusion during the procedure.
Seven of our patients became confused or had difficulty cooperating, and one experienced severe anxiety. The etiology of such mental status changes like confusion, or delirium can be difficult to determine in the midst of the procedure; however, the presence of pneumocephalus as shown by postoperative CT scan and the long duration of the procedure may be contributory factors. Also, other causes for intraoperative mental status changes might be from intracerebral bleeding, seizures, withdrawal of medications, patient fatigue and discomfort. The need for a sedative agent with properties that will not interfere with the process of physiologic localization, has little effect on the patient's motor symptomatology or respiratory status, and yet creates an environment in which the patient feels comfortable and relaxed is aptly demonstrated by the difficulties encountered in our patients.
In our series, 91% of the patients received sedation with propofol; therefore, no comparison with other sedatives/anesthetic regimens were statistically possible. An alternative anesthetic agent for DBS cases may be dexmedetomidine. The concern that dexmedetomidine may have adverse effects on neurophysiologic monitoring remains unresolved. [13] [14] [15] A recent report has described the use of dexmedetomidine during DBS placement 16 ; however, there are no randomized controlled trials to support the use of this drug over other agents. Further studies with dexmedetomidine will hopefully clarify its role for DBS procedures.
The retrospective nature of our report naturally presents a number of limitations. While we select the risk factors based on literature review and expert opinion, it is possible that other factors, associated with age, but not assessed herein could have been independently responsible for the observed complications. Examples might be the pattern of PD use, preoperative psychologic profile, substance abuse and comorbidities such as arthritis. It should also be appreciated that, while ours is among the largest DBS case series for which intraoperative complications have been systematically assessed, we still only had very limited statistical power to detect associations with category variables unless they were substantial. This was compounded by the fact that most of the variables studied were categorical and not continuous, such as age. Categorical variables require a much larger sample to show an association than continuous ones. Lastly, some complications might simply not have been recorded, especially if they were transient.
Recently, a variety of products have become available for frameless navigation targeting for DBS procedures. These approaches facilitate the preoperative planning of electrode trajectories and eliminate frame placement and scanning on the morning of the surgery. Together, these changes allow anesthesia and surgery to begin earlier in the morning, reducing the time off PD medications. Frameless navigation also allows for easier access to the airway and limited mobility in the neck. Nevertheless, current frameless DBS equipment remains somewhat cumbersome and carries significant disadvantages, including limiting the area over which deep brain mapping can be performed, and the need to prevent patients from sliding down on the OR table jeopardizing occipital skull mounted fiducials. In our practice we found frameless DBS to be a superior option for patients with chronic back pain who cannot tolerate long periods of immobilization, as well as for morbidly obese patients with a history of obstructive sleep apnea. We also use the frameless stereotactic apparatus in order to have easy access to the patient's airway.
Another problem pertaining to anesthetic management during DBS is the impairment of neuromuscular function in speech organs such as the larynx, leading to dysarthria in some patients with PD. PD patients with dysarthria are prone to the development of aspiration pneumonia. Our experience showed that respiratory complications, mainly aspiration, occurred in 1.6% of the cases. During the procedure we usually keep the oxygen saturation Z94% by increasing the oxygen concentration delivered to the patient and by careful titration of the sedation during the procedure or using sedation with minimal effects on upper airway reflexes to avoid aspiration.
CONCLUSION
This paper constitutes one of the largest series of intraoperative complications in DBS patients reported to date. It illustrates the perioperative difficulties that can be encountered during DBS implantation procedures. Monitored anesthesia care was the most common anesthesia technique used; and propofol was the sedative-hypnotic of choice for the majority of the procedures. Respiratory, neurologic and psychologic/ psychiatric complications can occur during and after DBS placement. Due to the retrospective nature of this study several methodologic limitations can be identified. Hopefully new anesthetic techniques and more clinical prospective studies will be developed and conducted in the future that can resolve some of these issues and lead to improved patient comfort and safety.
